Shuning completed her Bachelor’s Degree of Pharmaceutical Engineering at the China Pharmaceutical University, China. She will graduate from the University of Melbourne with a Master’s Degree in Biomedical Engineering at the end of 2018.
Shuning has also completed a Capstone Research Project into ‘Bio-MBCIU: Human Imaging Projects’ at the Melbourne Brain Centre Imaging Unit, finding the optimised image reconstruction parameter combinations for the amyloid PET/CT Standardized Uptake Value ratio (SUVr) to diagnose Alzheimer’s disease.
- 2018 Master of Engineering (Biomedical), University of Melbourne, Australia
- 2015 Bachelor of Engineering (Pharmaceutical), Pharmaceutical University, China
- A point-of-care lateral flow assay for neutralising antibodies against SARS-CoV-2.
Fulford TS, Van H, Gherardin NA, Zheng S, Ciula M, Drummer HE, Redmond S, Tan HX, Boo I, Center RJ, Li F, Grimley SL, Wines BD, Nguyen THO, Mordant FL, Ellenberg P, Rowntree LC, Kedzierski L, Cheng AC, Doolan DL, Matthews G, Bond K, Hogarth PM, McQuilten Z, Subbarao K, Kedzierska K, Juno JA, Wheatley AK, Kent SJ, Williamson DA, Purcell DFJ, Anderson DA, Godfrey DI
EBioMedicine. 2021 Dec; 74:103729
- Improving the coverage and accuracy of syphilis testing: The development of a novel rapid, point-of-care test for confirmatory testing of active syphilis infection and its early evaluation in China and South Africa.
Pham MD, Wise A, Garcia ML, Van H, Zheng S, Mohamed Y, Han Y, Wei WH, Yin YP, Chen XS, Dimech W, Braniff S, Technau KG, Luchters S, Anderson DA
EClinicalMedicine. 2020 Jul; 24:100440
News Articles (1)